ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -98.3% | 237,610 | -81.0% | 0.00% | -100.0% |
| Q2 2022 | $239,000 | +753.6% | 1,250,988 | +6996.6% | 0.00% | – |
| Q2 2020 | $28,000 | -24.3% | 17,628 | +88.6% | 0.00% | – |
| Q3 2019 | $37,000 | -65.1% | 9,345 | -38.0% | 0.00% | – |
| Q1 2019 | $106,000 | +30.9% | 15,070 | +1.7% | 0.00% | – |
| Q4 2018 | $81,000 | -49.1% | 14,819 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $159,000 | -34.3% | 14,819 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $242,000 | – | 18,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |